MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- J.B.CHEMICALS - ADCOCK INGRAM (S. Africa)
J.B.CHEMICALS vs ADCOCK INGRAM (S. Africa) - Comparison Results
J.B.CHEMICALS Change
JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More
ADCOCK INGRAM (S. Africa)
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
Financials
 J.B.CHEMICALS  ADCOCK INGRAM |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| J.B.CHEMICALS Mar-18 |
ADCOCK INGRAM Jun-14 |
J.B.CHEMICALS/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 363 | 291 | - | |
| Low | Rs | 255 | 210 | - | |
| Sales per share (Unadj.) | Rs | 169.1 | 86.7 | - | |
| Earnings per share (Unadj.) | Rs | 16.6 | -21.8 | - | |
| Cash flow per share (Unadj.) | Rs | 23.4 | -18.1 | - | |
| Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
| Dividend yield (eoy) | % | 0.6 | 0 | - | |
| Book value per share (Unadj.) | Rs | 172.5 | 68.0 | - | |
| Shares outstanding (eoy) | m | 83.57 | 168.78 | - | |
| Bonus/Rights/Conversions | BB | - | - | ||
| Price / Sales ratio | x | 1.8 | 2.9 | 63.2% | |
| Avg P/E ratio | x | 18.6 | -11.5 | -162.1% | |
| P/CF ratio (eoy) | x | 13.2 | -13.9 | -95.3% | |
| Price / Book Value ratio | x | 1.8 | 3.7 | 48.6% | |
| Dividend payout | % | 12.0 | 0 | - | |
| Avg Mkt Cap | Rs m | 25,827 | 42,338 | 61.0% | |
| No. of employees | `000 | 3.8 | 4.3 | 87.9% | |
| Total wages/salary | Rs m | 2,511 | 2,657 | 94.5% | |
| Avg. sales/employee | Rs Th | 3,747.4 | 3,408.5 | 109.9% | |
| Avg. wages/employee | Rs Th | 665.7 | 619.0 | 107.5% | |
| Avg. net profit/employee | Rs Th | 367.8 | -858.9 | -42.8% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 14,135 | 14,633 | 96.6% | |
| Other income | Rs m | 366 | 102 | 357.0% | |
| Total revenues | Rs m | 14,501 | 14,735 | 98.4% | |
| Gross profit | Rs m | 2,178 | -2,536 | -85.9% | |
| Depreciation | Rs m | 570 | 632 | 90.2% | |
| Interest | Rs m | 35 | 396 | 8.8% | |
| Profit before tax | Rs m | 1,940 | -3,461 | -56.0% | |
| Minority Interest | Rs m | 0 | -10 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
| Tax | Rs m | 552 | 216 | 255.4% | |
| Profit after tax | Rs m | 1,387 | -3,687 | -37.6% | |
| Gross profit margin | % | 15.4 | -17.3 | -88.9% | |
| Effective tax rate | % | 28.5 | -6.2 | -455.7% | |
| Net profit margin | % | 9.8 | -25.2 | -38.9% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 10,470 | 10,717 | 97.7% | |
| Current liabilities | Rs m | 2,749 | 6,030 | 45.6% | |
| Net working cap to sales | % | 54.6 | 32.0 | 170.5% | |
| Current ratio | x | 3.8 | 1.8 | 214.3% | |
| Inventory Days | Days | 55 | 111 | 49.8% | |
| Debtors Days | Days | 78 | 124 | 62.7% | |
| Net fixed assets | Rs m | 5,811 | 6,247 | 93.0% | |
| Share capital | Rs m | 167 | 68 | 246.0% | |
| Net worth | Rs m | 14,416 | 11,485 | 125.5% | |
| Long term debt | Rs m | 0 | 4,036 | 0.0% | |
| Total assets | Rs m | 17,649 | 21,696 | 81.3% | |
| Interest coverage | x | 56.6 | -7.7 | -731.7% | |
| Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
| Sales to assets ratio | x | 0.8 | 0.7 | 118.8% | |
| Return on assets | % | 8.1 | -15.2 | -53.1% | |
| Return on equity | % | 9.6 | -32.1 | -30.0% | |
| Return on capital | % | 13.7 | -19.8 | -69.1% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 1,231 | 1,249 | 98.5% | |
| From Investments | Rs m | -208 | -384 | 54.3% | |
| From Financial Activity | Rs m | -595 | 3,663 | -16.2% | |
| Net Cashflow | Rs m | 427 | 4,529 | 9.4% | |
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.02 Rs / ZAR
Compare J.B.CHEMICALS With: ACTAVIS (US) MYLAN (US) TEVA PHARMA (Israel)
Compare J.B.CHEMICALS With: AJANTA PHARMA SUVEN LIFESCIENCES ORCHID PHARMA LTD UNICHEM LAB AUROBINDO PHARMA
Today's Market
Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)
Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.
Related Views On News
J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)
Feb 6, 2020 | Updated on Feb 6, 2020For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)
May 24, 2019 | Updated on May 24, 2019For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)
Mar 28, 2019 | Updated on Mar 28, 2019Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.
More Views on NewsMost Popular
Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)
Mar 30, 2020This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...
The Biggest Trading Opportunity of 2020 is Here...
Mar 26, 2020India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!
A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)
Mar 25, 2020I see a big opportunity to make fast profits on the horizon.
Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)
Mar 24, 2020Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.
One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)
Apr 1, 2020A stock with strong moat is currently trading near 5-year lows.
More